Skip to main content
Annals of the American Thoracic Society logoLink to Annals of the American Thoracic Society
. 2024 Mar 1;21(3):486–498. doi: 10.1513/AnnalsATS.202305-402OC

The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Sheiphali A Gandhi 1,, Bohyung Min 2, Jane C Fazio 3, Kerri A Johannson 2, Craig Steinmaus 4, Carl J Reynolds 5, Kristin J Cummings 6
PMCID: PMC10913770  PMID: 38096107

Abstract

Rationale

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic pulmonary disorder of unknown etiology that is characterized by a usual interstitial pneumonia pattern. Previous meta-analyses have reported associations between occupational exposures and IPF, but higher-quality studies have been published in recent years, doubling the number of studied patients.

Objectives

To provide a contemporary and comprehensive assessment of the relationship between occupational exposures and IPF.

Methods

We searched PubMed, Embase, and Web of Science through July 2023 to identify all publications on occupational exposure and IPF. We conducted a meta-analysis of the occupational burden, odds ratio (OR), and population attributable fraction (PAF) of exposures. Five exposure categories were analyzed: vapors, gas, dust, and fumes (VGDF); metal dust; wood dust; silica dust; and agricultural dust. A comprehensive bias assessment was performed. The study protocol was registered in the International Prospective Register of Systematic Reviews (identifier CRD42021267808).

Results

Our search identified 23,942 publications. Sixteen publications contained relative risks needed to calculate pooled ORs and PAFs, and 12 additional publications reported an occupational burden within a case series. The proportion of cases with occupational exposures to VGDF was 44% (95% confidence interval [CI], 36–53%), with a range of 8–17% within more specific exposure categories. The pooled OR was increased for VGDF at 1.8 (95% CI, 1.3–2.4), with a pooled PAF of 21% (95% CI, 15–28%). ORs and PAFs, respectively, were found to be 1.6 and 7% for metal dust, 1.6 and 3% for wood dust, 1.8 and 14% for agricultural dust, and 1.8 and 4% for silica dust. The pooled ORs and PAFs within specific exposure categories ranged from 1.6 to 1.8 and from 4% to 14%, respectively. We identified some publication bias, but it was not sufficient to diminish the association between occupational exposures and IPF based on sensitivity analysis and bias assessment.

Conclusions

Our findings indicate that 21% of IPF cases (or approximately one in five) could be prevented by removal of occupational exposure (alongside a pooled OR of 1.8). Additionally, 44% of patients with IPF report occupational exposure to VGDF. This meta-analysis suggests that a considerable number of cases of IPF are attributable to inhaled occupational exposures and warrant increased consideration in the clinical care of patients and future prevention efforts.

Keywords: occupational lung disease, occupational exposures, pulmonary medicine, environmental exposures


Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrotic disorder typically affecting adults older than age 50 years and is associated with a poor prognosis. Its incidence ranges from three to nine cases per 100,000 annually in North America and Europe (1). The hallmark of IPF is a radiological or pathological usual interstitial pneumonia (UIP) pattern with known causes of UIP excluded (e.g., collagen vascular disease, drug-induced pneumonitis, radiation fibrosis, or occupational exposures) through a focused history or additional diagnostic testing (2, 3).

Although IPF is considered a disease of unknown etiology, profibrotic risk factors have been described, including genetic factors (4), cigarette smoking (5), viral infections (6), occupational exposures (7), and gastroesophageal reflux disease (8). In particular, the association with occupational exposures warrants further investigation, given the number of studies informing potential relationships (2). Additionally, occupational exposures remain a highly preventable and modifiable inhalational hazard if associated with IPF.

Retrospective case-control and cohort studies have found associations between specific occupational exposures and the risk of developing IPF. A previous systematic review of IPF and occupational exposures published in 2017 identified 11 studies that reported associations between occupational exposures and IPF (7, 912). This review included 1,229 cases of IPF, with only limited analysis of bias, confounding, susceptibility, and study quality (7). This present study was undertaken in light of new studies with large numbers of patients to evaluate whether their findings have continued to demonstrate an association between occupational exposures and IPF.

The primary objective of the present study was to provide a contemporaneous and comprehensive assessment of relationships between occupational exposures and IPF to qualitatively characterize associations between occupational exposures and the risk of diagnosis. This meta-analysis intends to improve upon previous work with an additional 5 years of research, during which a large number of studies have been published, using updated diagnostic definitions relevant to contemporary practice while integrating an analysis with intensive evaluation for bias and quality assessment.

Methods

Data Sources and Searches

We performed a systematic review and meta-analysis according to a predetermined protocol per the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (13, 14). We registered the study protocol to the International Prospective Register of Systematic Reviews on September 8, 2021 (identifier CRD42021267808).

The screening process and results are shown in Figure 1. We conducted an initial systematic electronic literature review using PubMed, Embase, and Web of Science on July 15, 2023. Searches were designed with the goal of identifying all publications that reported on occupational exposure in patients diagnosed with IPF. Search criteria are provided in the data supplement. We examined bibliographies to search for additional studies. No language or regional restrictions were applied. We excluded duplicates. We contacted authors for raw data or preprint papers for studies that had been published only as abstracts. If adequate data for analysis were available, abstracts were included.

Figure 1.


Figure 1.

Article selection process for meta-analysis using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. IPF = idiopathic pulmonary fibrosis; OR = odds ratio.

Study Selection

Two reviewers (S.A.G., B.M., and/or J.C.F.) independently screened all citations for eligibility using a sequential review of titles, abstracts, and full publications. At each stage, lists were compared, and disagreements were resolved through consensus (S.A.G., B.M., and/or J.C.F.). Per protocol, studies were included if the study population comprised adults (⩾18 years old) diagnosed with IPF (or equivalent criteria) based on consistent clinical, radiographic, or pathologic findings. The diagnosis was established according to the authors of the parent studies. Case-control, cohort, case-series, and cross-sectional studies were included, but studies with study populations of fewer than 10 were excluded. We included studies reporting prevalence or risk (odds ratio [OR], relative risk) of a diagnosis of IPF based on specific occupations or occupational exposures. In the event of multiple publications with overlapping recruitment periods at a single center, we included the study with the more detailed description of occupational exposure to prevent patients from being counted twice. Conference abstracts were included for pooled population attributable fraction (PAF) and OR calculation if the parent study authors provided raw data and methodological information for OR and PAF calculations and quality assessment.

Data Extraction and Quality Assessment

A standardized, prepiloted form was used to extract data from the included studies to assess study quality and evidence synthesis. Two review authors (S.A.G., B.M., and/or J.C.F.) extracted data independently, and discrepancies were identified and resolved through discussion (S.A.G., B.M., and/or J.C.F). Two authors (S.A.G., B.M., and/or J.C.F.) extracted data on study design, participant inclusion and exclusion criteria, sex, age, method of diagnosis, types of exposures, and effect measures (ORs, risk ratios, and standard errors). Aggregate participant data was used. For articles not in English, Google Translate was used for data extraction, which was verified by a native speaker (Google Translate version 6.34.0, 2022; Google LLC).

Inhalational exposure was defined by job or exposure history. In publications with sufficient data, analysis of occupational exposures in five exposure categories was performed: vapors, gas, dust, and fumes (VGDF); metal dust; wood dust; silica dust; and agricultural dust. Agricultural dust exposure was defined as exposure to farming, livestock, or organic dust. Silica dust exposure also included exposure to stonework or grinding if a discrete silica dust exposure category was not available. VGDF represents all other exposure categories combined, and, in selected studies, additional exposures.

Prespecified outcome measures included the proportion exposed and OR of diagnosis, with consideration of whether outcomes were adjusted for smoking history. The adjusted OR was extracted if unadjusted, and adjusted ORs are presented after adjustment for age, sex, or smoking. The methodological quality of studies, included in OR and PAF meta-analysis, was assessed independently by two coauthors (S.A.G. and C.J.R.) using the Risk of Bias in Studies estimating Prevalence of Exposure to Occupational risk factors (RoB-SPEO) tool (in eight categories) (15). Eight domains of bias were considered: selection, blinding, exposure misclassification, incomplete exposure data, selective reporting of exposures, conflict of interests, differences in numerator and denominator, and other biases. Risk of bias was rated in each domain: low, probably low, probably high, high, and no information, which were assigned scores of 1, 2, 3, 4, or 5, respectively. A cumulative score was calculated, with a lower score indicating a higher-quality study.

Statistical Methods and Meta-Analysis

Descriptive statistics were used to quantify the occupational burden of IPF (i.e., proportion of those with the disease who had occupational exposure). We pooled published or derived occupational burdens to obtain summary estimates using the metaproportion command in Stata software (version 14.2; StataCorp LP). For the occupational burden, we performed a subgroup analysis evaluating only full-text articles.

We estimated the occupationally related PAF reported by or derived from case-control studies. The PAF is the proportional reduction in population disease or mortality that would occur if exposure to a risk factor were eliminated. We calculated PAF using the OR and proportion of cases exposed as pc(OR − 1) / OR, where pc is the proportion of cases exposed (7, 16). We calculated pooled OR and pooled PAF for occupational exposures using a random-effects model with the metan command in Stata 14.2 (release 14; 2015). We selected a random-effects rather than a fixed-effects model because of between-study differences in design and populations. The pooled PAF relied on the ratio of attributable cases to all cases underlying each risk estimate. We also estimated statistical heterogeneity using I2 statistics.

To assess for publication bias, we analyzed a funnel plot for asymmetry. Additionally, we conducted a series of sensitivity analyses of studies to evaluate the impacts of various factors. Subgroup analysis was performed for pooled OR evaluating only studies adjusted for smoking and studies with larger sample sizes (case number >100). To analyze high-quality studies, we excluded those ranking in the bottom tertile of the overall quality assessment, analyzing studies with RoB-SPEO scores no greater than 16. An analysis of studies with “healthier” controls was performed, excluding studies that recruited controls from respiratory clinics or inpatient wards, because differing comparative groups could increase the heterogeneity of studies. Because some studies relied on chest X-ray rather than computed tomography (CT) of the chest for diagnosis, a subgroup analysis was performed for studies that required CT scans, consistent with contemporaneous guidelines (2, 3, 17). Finally, because of concerns for funnel plot asymmetry, Egger’s and Begg’s tests were also performed (18, 19).

Results

Search Results

Our initial search identified 23,942 citations, and 21,475 abstracts were reviewed after the removal of duplicates (Figure 1). Of these, 99 studies underwent full-text review, and 71 were excluded from data extraction. One study was excluded because of the omission of the proportion of exposed cases to calculate PAF (20), and we were able to include one study by contacting the authors for this calculation (21). Two conference abstracts were included in the calculations for pooled OR and PAF after we were able to contact the authors for raw data and methodological information for calculation and quality assessment (22, 23). One abstract was excluded because we were unable to gather this information and the authors did not plan to publish the study in a peer-reviewed journal (24). One study was found via published abstract in 2021 (25), with a peer-reviewed manuscript published in September 2023, which we were able to include in the analysis (26).

Study Characteristics

We identified 28 papers that met the inclusion criteria. Of these, 16 papers contained a risk estimate to calculate a pooled occupational burden, OR, and PAF, and 12 additional papers reported a proportion of IPF cases with occupational exposure (i.e., occupational burden) within a case-series/cross-section study.

Table 1 describes 16 case-control studies that contained a risk estimate to calculate a pooled OR and PAF (Table 1). One study by Awadalla and coworkers included separate risk estimates by sex. Therefore, two separate risk estimates are included in the calculations (27). The case-control studies included 2,631 patients with IPF (Table 1). Studies originated from nine countries and were published between 1990 and 2023. Early studies included patients in the IPF case population without a diagnosis by CT of the chest, relying instead on chest X-rays (2830). In one study, case and control definitions were unavailable at the time of this analysis (23). In creating control groups, five studies used the general population (21, 3134), one used an employment registry (35), and the remainder used clinical practices at participating centers. Of these, four recruited control subjects from respiratory clinics or inpatient pulmonary wards consisting of patients without IPF (26, 27, 36, 37). Nine of 15 studies relied on exposure assessment based solely on a questionnaire or patient interview without a job-exposure matrix (2730, 32, 33, 3638). Two studies did not adjust the risk estimates for smoking (26, 30).

Table 1.

Overview of occupational idiopathic pulmonary fibrosis case-control studies

Study, Year, Location Cases Case Definition Control Definition Exposure Measure Occupational Burden
VGDF Metal Wood Agri Silica
Scott et al., 1990, UK (28) 40 Clinical assessment; CXR; PFTs Matched on age and sex of cases using general practice register, ratio 1:4 Questionnaire 68% 15% 15% 13% 15%
Hubbard et al., 1996, UK (29) 218 Clinical assessment; CXR; CT; PFTs; biopsy Matched on age and sex of cases using general practice register, ratio 1:4 Telephone interview; questionnaire 25% 14% NA NA NA
Mullen et al., 1998, UK (30) 15 CXR or biopsy Matched on age and sex of cases using orthopedic practice list, ratio 1:6 Telephone Interview 40% NA 13% NA NA
Baumgartner et al., 2000, US (31) 248 Clinical assessment; CT; BAL; biopsy Matched on age, sex, and geographic region of cases using random digit dialing, ratio 1:2 Telephone Interview; JEM NA 10% 5% 25% 3%
Hubbard et al., 2000, UK (35) 22 Death certificate Random sample of deceased Rolls Royce employees, ratio 1:10 JEM NA 59% NA NA NA
Miyake et al., 2005, Japan (36) 102 Clinical assessment; CT; biopsy Respiratory department inpatients at 21 participating hospitals, unmatched, 2:1 ratio Questionnaire 32% 12% 5% NA 11%
Gustafson et al., 2007, Sweden (32) 140 Pulmonary fibrosis of unknown cause, requiring LTOT, identified from LTOT register Random age-matched population sample, 1:5 ratio Questionnaire 61% 5% 3% NA 10%
García-Sancho et al., 2011, Mexico (33) 100 Clinical assessment; CT; biopsy Matched on age, sex, and geographic region using neighborhood sampling ratio 1:1–1:3 Questionnaire 77% NA NA NA NA
Awadalla et al., 2012, Egypt (27) 106 women,
95 men
Clinical assessment; CT; PFTs Matched on age, sex, residence and smoking, non-IPF respiratory inpatients 1:1 Clinical Interview NA NA 8% 21% 2%
NA 18% 16% 21% 13%
Koo et al., 2017, S. Korea (37) 78 Clinical assessment; CT Matched on age, sex, and area, ratio 1:1, recruited from respiratory inpatients and outpatients Telephone Interview 55% 27% 8% NA 27%
Kim et al., 2017, S. Korea (38) 70 Clinical assessment; CT; biopsy Matched on age and sex from healthy clinic visits; 1:1 ratio Telephone Interview; JEM NA 13% 10% 23% 14%
Paolocci et al., 2018, Italy (21) 69 Clinical assessment; CT; biopsy Matched on area but not age or sex from general population Telephone Interview; JEM 87% 13% 9% 54% NA
Reynolds et al., 2019, UK (22) 488 Clinical assessment; CT; biopsy Matched on age and sex from outpatient clinics, 1:1 ratio, study recruited only men Telephone Interview; JEM 28% 18% 10% NA 5%
Abramson et al., 2020, Australia (34) 503 Clinical assessment; CT; biopsy Matched on age, sex, and state of residence using random digit dialing, ratio 2:1 Telephone Interview; JEM 52% 11% 1% 9% 13%
Park et al., 2020, S. Korea (23) 206 Unknown Without lung disease Questionnaire, JEM 25% 2% 5% 11% 10%
Zubairi et al., 2023, Pakistan (25, 26) 131 Clinical assessment, PFTs, HRCT Matched on age and sex, non-IPF respiratory patients inpatient and outpatient Questionnaire 19% NA NA NA NA

Definition of abbreviations: Agri = agricultural dust; BAL = bronchoalveolar lavage; CT = computed tomography (thorax); CXR = chest X-ray; HRCT = high-resolution computed tomography; JEM = job exposure matrix; LTOT = long-term oxygen therapy; NA = not available; PFT = pulmonary function test; VGDF = vapors, gas, dust, or fumes, which represent all the exposure categories shown combined and, in selected studies, additional exposures.

An additional 12 studies met the inclusion criteria and reported proportions of cases with occupational exposure to calculate an occupational burden (Table 2). Of these, two studies were cross-sectional (39, 40) and eight were case series (4147). A total of 21 studies were used to calculate the occupational burden of VGDF. One article was published in Turkish (44). Only one of these 11 studies used chest X-rays rather than CT scans for the case definition of IPF (39), and one study relied on pathological findings (45). One case-control study was not included in the occupational burden calculation as a result of likely overlap of patients within a larger cross-sectional study (23). Two studies assessed the addition of an occupational medicine provider to a multidisciplinary discussion (48, 49), but one of them did not contain a sufficient sample size to meet the inclusion criteria (49). Finally, one abstract did not provide the case definition (43, 46). Of the studies with known exposure methods, four studies used job-exposure matrices (40, 41, 44, 48) and five used questionnaires or interviews to determine exposure (39, 42, 46, 50).

Table 2.

Overview and occupational burden of idiopathic pulmonary fibrosis cross-sectional and descriptive studies

Study, Year, Location Cases Case Definition Exposure Measure Full Text Occupational Burden
VGDF Metal Wood Agri Silica
Johnston et al., 1997, UK (39) 588 Clinical assessment; CXR; PFT; biopsy Physician-administered questionnaire Yes 47% NA NA 19% NA
Sengül et al., 2009, Turkey (44) 25 Clinical assessment; CT; biopsy Clinical interview; JEM Yes 48% 16% NA 16% NA
Lee et al., 2015, S. Korea (41) 1,311 Clinical assessment; CT; PFT Questionnaire; JEM Yes 13% NA NA 18% NA
Alaa Rashad and Ibrahim, 2015, Egypt (50) 568 Clinical assessment; CT; PFT Clinical Interview Yes NA NA NA 12% NA
Walters et al., 2015, Australia (46) 389 Unknown Questionnaire No 50% NA NA 7% 12%
Wuyts et al., 2016, Belgium/Luxembourg (47) 175 Clinical assessment; CT; PFT Unknown No 43% 8% NA NA NA
Liviero et al., 2017, Italy (43) 44 Unknown Unknown No 36% NA NA NA NA
Toyoshima et al., 2020, Japan (45) 195 Biopsy Unknown No 22% NA NA NA NA
Lee et al., 2021, US (42) 41 Clinical assessment; CT; biopsy Questionnaire Yes 56% 12% NA 17% 7%
Sese et al., 2021, France (40) 200 CT; biopsy JEM Yes 26% 11% 3% 6% 2%
Jegal et al., 2022, S. Korea (64) 1,775 Clinical assessment; CT; biopsy Clinical interview; questionnaire Yes 30% 6% 5% 9% 10%
Carlier et al., 2022, France (48) 31 Clinical assessment, CT Clinical interview; questionnaire Yes 45% 42% 23% NA 35%

Definition of abbreviations: Agri = agricultural dusts; BAL = bronchoalveolar lavage; CT = computed tomography (thorax); CXR = chest X-ray; JEM = job exposure matrix; NA = not available; PFT = pulmonary function test; VGDF = vapors, gas, dust, or fumes, which represent all the exposure categories shown combined and, in selected studies, additional exposures.

Meta-Analysis

The reported estimates of individual studies for occupational burden are listed in Table 2. Twenty-one studies were used to calculate the occupational burden of VGDF (10 case-control studies and 11 cross-sectional studies or case series). The occupational burden (i.e., proportion with occupational exposure) for VGDF among patients with IPF was 44% (95% confidence interval [CI], 35–56%; Figure 2). Table 3 demonstrates additional exposure categories, in which metal dusts contributed a burden of 16% (95% CI, 12–19%), wood dust 8% (95% CI, 6–11%), agricultural dusts 16% (95% CI, 13–20%), and silica dust 10% (95% CI, 7–13%). Subgroup analysis limited to published full-text studies demonstrated a higher occupational burden of 47% (95% CI, 37–58%) based on 16 studies. Forest plots for the pooled occupational burden of the subcategories are provided in the data supplement.

Figure 2.


Figure 2.

Idiopathic pulmonary fibrosis (IPF) occupational burden. Forest plot of studies relevant to estimating the contribution of work exposures to IPF. The occupational prevalence of IPF, confidence interval (CI), and weighted contribution for each study are shown, as are the calculated pooled estimate (red dashed line) and 95% CI. The pooled proportion of occupational IPF among all IPF cases is 46% (95% CI, 37–55%). ES = effect size.

Table 3.

Pooled occupational burden (proportion) estimates for occupation and idiopathic pulmonary fibrosis

Exposure Estimate Occupational Burden (95% CI)
VGDF 21 44% (36–53%)
Metal dusts 18 16% (12–19%)
Wood dusts 16 8% (6–11%)
Agricultural dusts 15 16% (13–20%)
Silica/stone dust 16 10% (7–13%)

Definition of abbreviations: CI = confidence interval; VGDF = vapors, gas, dust, or fumes, which represent all the other exposure categories shown combined, and, in selected studies, additional exposures.

Awadalla and colleagues (27) stratified their study sample by male and female, contributing two risk estimates to the wood, agricultural, and silica subcategories.

The reported estimates of individual case-control studies are listed in Table 4. The pooled ORs and PAFs for each exposure category are provided in Table 5. The pooled OR for VGDF was 1.8 (95% CI, 1.3–2.4), with a pooled PAF of 21% (95% CI, 15–28%) based on 11 risk estimates (Figure 3). There was no relationship between publication year and OR. The ORs and PAFs, respectively, were found to be 1.6 and 7% (metal dust), 1.6 and 3% (wood dust), 1.8 and 14% (agricultural dust), and 1.8 and 4% (silica dust). The pooled ORs and PAFs for specific exposure categories are provided in Table 5, with forest plots provided in the data supplement.

Table 4.

Case-control studies of occupational risk factors for idiopathic pulmonary fibrosis

Study, Year, Location, Reference Cases OR (95% CI)
PAF
VGDF Metal Wood Agri Silica VGDF Metal Wood Agri Silica
Scott et al., 1990, UK (28) 40 1.3 (0.8–2.0) 11.0 (2.3–52.4) 2.9 (0.9–9.9) 10.9 (1.2–96.0) 1.6 (0.5–4.8) 17% 12% 10% 12% 5%
Hubbard et al., 1996, UK (29) 218 NA 1.7 (1.1–2.7) 1.7 (1.0–2.9) NA NA NA 9% 6% NA NA
Mullen et al., 1998, UK (30) 15 2.4 (0.7–8.4) NA 3.3 (0.4–25.8) NA 11.0 (1.1–115.0) 20% NA 7% NA 20
Baumgartner et al., 2000, US (31) 248 NA 2.0 (1.0–4.0) 1.6 (0.8–3.3) 1.6 (1.0–2.5) 3.9 (1.2–12.7) NA 5% 3% 9% 2%
Hubbard et al., 2000, UK (35) 22 NA 1.1 (0.4–2.7) NA NA NA NA 5% NA NA NA
Miyake et al., 2005, Japan (36) 102 5.6 (2.1–17.9) 9.6 (1.7–181.1) NA NA 1.8 (0.5–7.0) 26% 11% NA NA 5%
Gustafson et al., 2007, Sweden (32) 140 1.1 (0.7–1.7) 0.9 (0.5–1.6) 1.2 (0.7–2.2) NA 1.4 (0.7–2.7) 6% NA 3% NA 3%
García-Sancho et al., 2011, Mexico (33) 100 2.8 (1.5–5.5) NA NA NA NA 50% NA NA NA NA
Awadalla et al., 2012, Egypt (27)                      
 Men 95 NA 1.6 (0.7–3.6) 2.7 (1.0–7.4) 1.0 (0.4–2.3) 1.1 (0.5–2.7) NA 6% 9% NA 1%
 Women 106 NA NA 4.3 (0.8–22.1) 3.3 (1.2–10.1) NA NA NA 6% 14% NA
Kim et al., 2017, S. Korea (38) 70 NA 0.8 (0.2–3.9) 1.2 (0.3–4.4) 4.5 (1.3–16.2) 8.8 (1.1–73.5) NA NA 1% 17% 13%
Koo et al., 2017, S. Korea (37) 78 2.7 (0.7–10.9) 5.0 (1.4–18.2) 2.5 (0.5–12.3) NA 1.2 (0.4–3.8) 35% 22% 5% NA 5%
Paolocci et al., 2018, Italy (21) 69 4.1 (2.3–7.5) 3.8 (1.2–12.2) 1.4 (0.5–4.0) 2.4 (1.3–4.3) NA 67% 10% 3% 32% NA
Reynolds et al., 2019, UK (22) 466 1.7 (1.2–2.3) 1.4 (0.9–2.0) 1.4 (0.9–2.3) NA 2.9 (1.3–6.7) 12% 5% 3% NA 3%
Abramson et al., 2020, Australia (34) 503 1.1 (0.9–1.4) 1.3 (0.9–1.9) 0.7 (0.3–1.8) 1.0 (0.7–1.5) 0.6 (0.4–0.8) 3 3 NA NA NA
Park et al., 2020, S. Korea (23) 206 2.1 (1.2–3.7) 0.8 (0.2–2.9) 2.1 (0.7–7.7) 1.8 (0.9–3.9) 2.5 (1.0–6.7) 18% NA 2% NA 6%
Zubairi et al., 2023, Pakistan (25, 26) 131 1.1 (0.7–1.7) NA NA NA NA 2% NA NA NA NA

Definition of abbreviations: Agri = agricultural dusts; CI = confidence interval; NA = not available; OR = odds ratio; PAF = population attributable fraction; VGDF = vapors, gas, dust, or fumes, which represent all the exposure categories shown combined and, in selected studies, additional exposures.

Table 5.

Pooled OR and PAF estimates for occupation and idiopathic pulmonary fibrosis

Exposure Risk Estimates Pooled OR (95% CI) Pooled PAF (95% CI)
VGDF 11 1.8 (1.3-2.4) 21% (15–28%)
Metal dusts 13 1.6 (1.2-2.1) 7% (5–10%)
Wood dusts 13 1.6 (1.2-2.0) 3% (2–4%)
Agricultural dusts 8 1.8 (1.2-2.7) 14% (8–20%)
Silica 11 1.8 (1.1-3.0) 4% (2–5%)

Definition of abbreviations: CI = confidence interval; OR = odds ratio; PAF = population attributable fraction; VGDF = vapors, gas, dust, or fumes, which represent all the other exposure categories shown combined, and, in selected studies, additional exposures.

Awadalla and colleagues (27) stratified their study sample by male and female, contributing two risk estimates to the wood, agricultural, and silica subcategories.

Figure 3.


Figure 3.

Idiopathic pulmonary fibrosis (IPF) odds ratio (OR) and population attributable fraction (PAF) for vapors, gas, dust, or fumes from case-control studies. Forest plot of articles relevant to estimating the occupational contribution to IPF of vapors, gas, dust, or fumes (combined categories of exposure considered in the studies included). The estimated OR (A) and PAF (B), confidence interval (CI), and weighted contribution for each study are shown, as are the calculated pooled estimate (red dashed line) and 95% CI. (A) The pooled OR is 1.9 (95% CI, 1.4–2.6). (B) The pooled PAF is 24% (95% CI, 16–32%). ES = effect size.

Heterogeneity and Bias Assessment

To investigate possible publication bias, we looked for funnel plot asymmetry for VGDF (Figure 4A), which visually appears to show a decreased number of studies with ORs of less than 1.0 among those studies with larger standard errors. A series of sensitivity analyses demonstrated a similar pooled OR for VGDF. Studies with larger sample sizes demonstrated a pooled OR for VGDF of 1.5 (95% CI, 1.1–2.0). The sensitivity analysis for VGDF among studies with OR adjusted for smoking was similar at 1.9 (95% CI, 1.4–2.7), with a pooled PAF of 24% (95% CI, 16–33%). Studies with healthier controls recruited from the general population or from populations outside of respiratory clinics demonstrated a pooled OR of 1.7 (95% CI, 1.3–2.4) and a PAF of 22% (95% CI, 13–31%). An additional sensitivity analysis was performed of studies that required CT scans for diagnosis based on the 2000 American Thoracic Society and European Respiratory Society International Consensus Statement (17). This analysis demonstrated an OR of 1.9 (95% CI, 1.3–2.6) and a PAF of 22% (95% CI, 14–29%).

Figure 4.


Figure 4.

(A) Funnel plot for meta-analysis. To investigate possible publication bias, we looked for funnel plot asymmetry for vapors, gas, dust, or fumes, which visually appears to show a decreased number of studies with odds ratios of less than 1.0 among studies with larger standard errors (demonstrated by the hollow red square). (B) Egger’s test for publication bias. The Egger’s test is a linear regression of the effect estimates on their standard errors weighted by their inverse variance. Using the Egger’s test, we found some evidence of publication bias for vapors, gas, dust, or fumes (P = 0.02), agricultural dust (P = 0.03), and silica dust (P < 0.01), but not for metal dust (P = 0.10) or wood dust (P = 0.13). CI = confidence interval.

There was heterogeneity in case-control studies of occupational exposures in IPF. The I2 statistics for the 11 studies used to calculate the pooled OR were 71.9% for VGDF and 71.0% for silica dust. They were lower for metal dust (42.9%) and agricultural dust (55.1%). Wood dust demonstrated low heterogeneity, with an I2 statistic of 0%. Using Egger’s test (Figure 4B), we found some evidence of publication bias for VGDF (P = 0.02), agricultural dust (P = 0.03), and silica dust (P < 0.01), but not for metal dust (P = 0.10) or wood dust (P = 0.13). Begg’s test demonstrated a P value of 0.15 for VGDF, which does not indicate publication bias due to excessive influence of studies with small sample sizes.

Because of the possibilities of methodological issues, we tabulated study case and control definitions and exposure methods. We assessed the risk of bias using the RoB-SPEO tool (Table 6) (15). The median cumulative RoB-SPEO score was measured at 16. A high-quality subgroup analysis that focused on the seven studies with total scores no greater than 16 (21, 22, 28, 30, 33, 34, 37) found that the pooled OR for VGDF was similar to that of the overall analysis at 1.9 (95% CI, 1.3–2.8), with a similar I2 statistic of 75.5%.

Table 6.

RoB-SPEO risk of bias scores for occupational idiopathic pulmonary fibrosis articles

Study, Year S B E I SR C D O Total
Scott et al.,1990 (28) 3 4 2 2 3 1 1 1 16
Hubbard et al., 1996 (29) 3 2 2 2 3 1 1 1 14
Mullen et al., 1998 (30) 3 2 2 2 3 1 1 4 14
Baumgartner et al., 2000 (31) 3 2 2 2 3 1 1 1 14
Hubbard et al., 2000 (35) 4 4 2 3 3 2 1 2 19
Miyake et al., 2005 (36) 4 4 2 3 3 1 1 1 18
Gustafson et al., 2007 (32) 4 4 2 3 3 1 1 1 18
García-Sancho et al., 2011 (33) 3 3 2 3 3 1 1 1 16
Awadalla et al., 2012 (27) 4 4 2 3 3 1 1 1 18
Kim et al., 2017 (38) 4 4 2 2 2 1 1 1 16
Koo et al., 2017 (37) 4 2 2 2 3 1 1 1 15
Paolocci et al., 2018 (21) 3 2 3 3 2 1 1 1 15
Reynolds et al., 2019 (22) 1 1 3 3 3 1 1 1 13
Abramson et al., 2020 (34) 2 2 1 2 1 1 1 1 10
Park et al., 2020 (23) 5 2 3 3 3 1 1 1 18
Zubairi et al., 2023 (26) 4 4 2 3 3 1 1 1 19

Definition of abbreviations: B = blinding; C = conflict of interests; D = differences in the numerator and denominator; E = exposure misclassification; I = incomplete exposure data; O = other bias; RoB-SPEO = Risk of Bias in Studies estimating Prevalence of Exposure to Occupational risk factors; S = selection; SR = selective reporting of exposures.

Eight domains of bias were considered: selection, blinding, exposure misclassification, incomplete exposure data, selective reporting of exposures, conflict of interests, differences in the numerator and denominator, and other bias. Risk of bias was rated in each domain: 1 = low; 2 = probably low; 3 = probably high; 4 = high; and 5 = no information.

Discussion

This meta-analysis indicates that a considerable number of cases of IPF are attributable to inhaled occupational exposures. The proportion of cases with occupational exposures to VGDF was 44%, with a range of 8–16% within more specific exposure categories. The pooled OR was increased for VGDF at 1.8, with a pooled PAF of 21%. The ORs and PAFs, respectively, were found to be 1.6 and 7% (metal dust), 1.6 and 3% (wood dust), 1.8 and 14% (agricultural dust), and 1.8 and 4% (silica dust). Taken together, our findings indicate that 21% of IPF cases (or approximately one in five) could be prevented by removal of occupational exposure to VGDF.

These findings are important, given that IPF is otherwise considered a diagnosis without a known cause. Identifying potentially pathogenic occupational exposures is important because they are preventable through proper workplace engineering controls and personal protective equipment. Emphasis has been placed on clearly occupational fibrotic lung diseases such as asbestosis and silicosis, but a clear connection between occupational exposures and other fibrotic lung diseases such as IPF can motivate the introduction of further exposure controls. For example, the recognition of an association between agricultural dust and fibrotic lung disease could prompt further investigation into the pathophysiologic mechanism, as well as increased emphasis on lowering dust exposure in the workplace. Physicians often fail to document a thorough occupational exposure history despite the fact that occupational exposures are responsible for 860,000 illnesses annually (51, 52). Recognition of such associations could benefit patients with IPF and their families by affording them the opportunity to apply for fair compensation, and could benefit current and future workers through exposure and disease prevention.

Our analysis found increased risks of IPF with metal dust, wood dust, agricultural dust, and silica dust. The diagnosis of IPF based on radiographic and pathologic findings of UIP without clear etiology is fraught with danger for premature diagnosis without complete evaluation of etiologies. Occupational exposures, including organic, metal, and silica dust, can cause similar findings on clinical presentation. Many have postulated that work exposure may trigger a profibrotic response that is clinically indistinguishable from IPF. Organic and inorganic dust have demonstrated the development of a UIP pattern on imaging, and, without a thorough occupational exposure assessment, pulmonary fibrosis may be misclassified as idiopathic.

Agricultural and wood dusts fall under the category of organic dusts, and the pathogenesis of organic dust to lung fibrosis is not completely clear. However, the possibility of unrecognized end-stage fibrotic hypersensitivity pneumonitis (HP) cannot be excluded because this can have a UIP pattern (53). Fibrotic HP can be easily confused with IPF even by experienced physicians, especially if patients have negative precipitins or have been removed from exposure by the time of clinical evaluation. A study by Morell and colleagues found that 20 of 46 patients initially diagnosed with IPF later had their diagnosis changed to HP with additional history of exposure to animal antigens (54). There also must be the consideration of a fibrogenic process of organic dust causing pulmonary fibrosis that is yet to be described (55).

Studies that use mineralogical analysis techniques have found metal dusts (e.g., nickel, iron, and aluminum) as well as silica in the lymph node and lung tissue of patients with pulmonary fibrosis, even though a clear causation was not established (56, 57). The association between lung fibrosis and metal dust exposure can be explained by the transition of alveolar cells to mesenchymal cells caused by reactive oxygen species (ROS), and other metals can induce ROS (58, 59). These ROS can induce a fibrotic response that can appear radiographically as UIP. Silica dust exposure is associated with profibrotic response through similar means of induction of free radicals, leading to inflammation and eventual fibrosis (60). Silica particles found on biopsies of patients with IPF were associated with a more rapid decline of pulmonary function (61). A recent study demonstrated that 16–20% of silica-exposed Korean workers who had received compensation for pneumoconiosis had radiographic findings consistent with UIP (62). However, we cannot discount the possible coexposure of asbestos in the metalworking and construction industries, especially among those working in steel mills in the 20th century (63).

This meta-analysis is a contemporaneous evaluation of occupational exposures and IPF and strengthens previous findings with the inclusion of high-quality studies that have been published since prior reviews. A major strength of this meta-analysis is the inclusion of an additional six case-control studies that have been published on the topic since the last major review, more than doubling the number of patients with IPF analyzed at 2,631 cases. A review by Blanc and coworkers was conducted in 2019 and included 1,229 cases of IPF, with only limited analysis of bias, confounding, susceptibility, and study quality (7). Of the six new studies with risk estimates, four had RoB-SPEO scores of 16 or lower, indicating they were high in quality. These six studies used updated diagnostic definitions that are more relevant to today’s practice. Another interim review by Park and colleagues included two further studies that were published since the review of Blanc and coworkers, but this analysis did not include an overall VGDF assessment or assess occupational burden or PAF calculations, limiting the scope of their assessment (5). Additionally, they combined occupational and environmental exposures rather than discerning only occupational exposure. Uniquely, we included conference abstracts in our screening and analysis, provided they included adequate data, as well as papers not published in English, which have not consistently been included in past reviews. Our included articles represent a more comprehensive range of regions of the world, with many studies from Asia and Central/South America compared with other studies (including a study published in Turkish). Additionally, the inclusion of conference abstracts and a wide range of study types extended our search beyond those of other studies, ensuring a thorough literature review. We have ameliorated and updated the analysis with a high-quality literature search, extensive sensitivity analysis, and bias assessment to develop a more solid foundation of association.

A thorough assessment of publication bias was performed, and, in general, results were similar across analyses, demonstrating the robustness of our findings. Even though the I2 statistic shows marked heterogeneity in study results, heterogeneity was expected because of the differences across exposures, study populations, and study designs. All ORs in the pooled OR calculation for VGDF were greater than 1.0, demonstrating homogeneity and strengthening our findings. To further evaluate for publication bias, we analyzed the pool OR of studies with larger sample sizes, demonstrating a pooled OR of 1.5, reinforcing our findings, in addition to consistent findings in only studies of higher quality (OR = 1.9), studies adjusted for smoking (OR = 1.9), and studies that required CT scans for IPF diagnosis (OR = 1.9). The Egger’s test demonstrated funnel plot asymmetry for VGDF, agricultural dust, and silica dust exposures, which may indicate concern for publication bias, with fewer papers published with an OR of less than 1.0. The Begg’s test did not demonstrate publication bias in VGDF, demonstrating that studies with small sample sizes did not excessively influence our findings. The tests for publication bias did demonstrate that some may be present, emphasizing the importance of publishing negative results; nevertheless, the impact of publication bias is not sufficient to diminish the association between occupational exposures and IPF.

This study has limitations, primarily based on the quality of the parent studies. Heterogeneity was high, especially for the VGDF calculations, even though all risk estimates demonstrated an OR greater than 1. A thorough sensitivity analysis was performed, but not all heterogeneity was explained. Variability could be present as a result of differential assessment of occupational exposure by clinicians conducting the case-control studies, whereby patients with occupational exposure were less likely to be diagnosed with IPF. There was additional variability present in control group definitions. Subgroup analysis for healthier controls did not explain the overall heterogeneity. The remaining heterogeneity should inform future study design, including the need for a standardized questionnaire and control groups to assess occupational exposures. Recall bias is likely because many studies relied on clinical interviews and questionnaires to gather occupational exposure history. Six of 16 studies used a job-exposure matrix with the intent to decrease differential recall of exposures, and, as noted, we considered these to be of higher quality. Only one study grouped environmental and occupational exposures to VGDF (38). Therefore, there is the possibility for a misclassified source of exposure, but this risk was believed to be low. There is a lack of industrial hygiene confirmation of exposures through objective exposure measurement (e.g., dust air sampling) or duration of exposure, which is a common limitation of many occupational exposure studies. Our overall bias assessment performed with the Rob-SPEO tool (15) showed that, collectively, these studies were at risk for bias arising from selection, lack of blinding, exposure misclassification, incomplete exposure data, and selective reporting of exposures. However, on average, the quality rating fell into the “probably low risk” category. These limitations again emphasize the importance of future studies conducted with high-quality exposure methods to further elucidate the relationship between occupational exposures and IPF.

In summary, this study reports associations between inhalational occupational exposures and the diagnosis of IPF, an otherwise idiopathic disease with a poor prognosis and increasing epidemiology. Despite limitations of heterogeneity and varied exposure assessment, a substantive portion of patients diagnosed with IPF have disease that is likely attributed to occupational exposures to VGDF, including agricultural, wood, metal, and silica dusts. Recognizing this association as a preventable form of pulmonary fibrosis is paramount to further preventive efforts within workspaces and the environment to improve lung health.

Footnotes

Supported by National Institute of Health National Research Service Award/National Cancer Institute grant 1F32CA265103-01 (S.A.G.). The findings and conclusions in this article are those of the authors and do not necessarily represent the views or opinions of the California Department of Public Health or the California Health and Human Services Agency.

Author Contributions: S.A.G., J.C.F., and B.M. conducted article screening and data extraction. S.A.G., C.S., and C.J.R. conducted bias assessment and sensitivity analysis. S.A.G. and C.J.R. conducted the meta-analysis. All authors contributed substantially to the study design, data analysis and interpretation, and the writing of the manuscript. S.A.G. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

This article has a data supplement, which is accessible from this issue’s table of contents at www.atsjournals.org.

Author disclosures are available with the text of this article at www.atsjournals.org.

References

  • 1. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J . 2015;46:795–806. doi: 10.1183/09031936.00185114. [DOI] [PubMed] [Google Scholar]
  • 2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med . 2011;183:788–824. doi: 10.1164/rccm.2009-040GL. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. American Thoracic Society European Respiratory society; Japanese Respiratory Society; Latin American Thoracic Association. An official ATS/ERS/JRS/ALAT Clinical Practice Guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med . 2015;192:e3–e19. doi: 10.1164/rccm.201506-1063ST. [DOI] [PubMed] [Google Scholar]
  • 4. Kaur A, Mathai SK, Schwartz DA. Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment. Front Med (Lausanne) . 2017;4:154. doi: 10.3389/fmed.2017.00154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Park Y, Ahn C, Kim TH. Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses. Sci Rep . 2021;11:4318. doi: 10.1038/s41598-021-81591-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Mostafaei S, Sayad B, Azar MEF, Doroudian M, Hadifar S, Behrouzi A, et al. The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis. Respir Res . 2021;22:53. doi: 10.1186/s12931-021-01650-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement. Am J Respir Crit Care Med . 2019;199:1312–1334. doi: 10.1164/rccm.201904-0717ST. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Bédard Méthot D, Leblanc É, Lacasse Y. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Chest . 2019;155:33–43. doi: 10.1016/j.chest.2018.07.038. [DOI] [PubMed] [Google Scholar]
  • 9. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc . 2006;3:293–298. doi: 10.1513/pats.200512-131TK. [DOI] [PubMed] [Google Scholar]
  • 10. Turner-Warwick M. In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many? Thorax . 1998;53(suppl 2):S3–S9. doi: 10.1136/thx.53.2008.s3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hubbard R. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J Suppl . 2001;32(suppl):119s–121s. [PubMed] [Google Scholar]
  • 12. Gulati M, Redlich CA. Asbestosis and environmental causes of usual interstitial pneumonia. Curr Opin Pulm Med . 2015;21:193–200. doi: 10.1097/MCP.0000000000000144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med . 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ . 2021;372:n71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, et al. RoB-SPEO: a tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO joint estimates of the work-related burden of disease and injury. Environ Int . 2020;135:105039. doi: 10.1016/j.envint.2019.105039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2010;182:693–718. doi: 10.1164/rccm.200811-1757ST. [DOI] [PubMed] [Google Scholar]
  • 17. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med . 2000;161:646–664. doi: 10.1164/ajrccm.161.2.ats3-00. [DOI] [PubMed] [Google Scholar]
  • 18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ . 1997;315:629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics . 1994;50:1088–1101. [PubMed] [Google Scholar]
  • 20. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med . 1994;150:670–675. doi: 10.1164/ajrccm.150.3.8087336. [DOI] [PubMed] [Google Scholar]
  • 21. Paolocci G, Folletti I, Torén K, Ekström M, Dell’Omo M, Muzi G, et al. Occupational risk factors for idiopathic pulmonary fibrosis in Southern Europe: a case-control study. BMC Pulm Med . 2018;18:75. doi: 10.1186/s12890-018-0644-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Reynolds C, Sisodia R, Barber C, Cullinan P. S23 Occupational exposures to wood, metal, and stone in IPF; findings from the idiopathic pulmonary fibrosis job exposures study (IPFJES) Thorax . 2019;74:A78. [Google Scholar]
  • 23. Park J, Park Y, Lim S, et al. Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a case-control study of South Korea. Am J Respir Crit Care Med . 2020;201:A3379. [Google Scholar]
  • 24. Zamora A, Olson AL, Brown KK, Van Dyke M, Maier LA, Swigris JJ. Occupational exposures (OE) and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 2012;185:A5176. [Google Scholar]
  • 25. Zubairi A, Rabbani U, Hassan M, et al. Risk factors of idiopathic pulmonary fibrosis in Pakistani population: a matched case-control study. Chest . 2021;160(suppl):A1259. doi: 10.47391/JPMA.6099. [DOI] [PubMed] [Google Scholar]
  • 26. Sarwar Zubairi AB, Rabbani U, Hassan M, Fatmi Z, Ahmed N, Ali AS, et al. Risk factors of idiopathic pulmonary fibrosis in Pakistani population: a matched case-control study. J Pak Med Assoc . 2023;73:1782–1787. doi: 10.47391/JPMA.6099. [DOI] [PubMed] [Google Scholar]
  • 27. Awadalla NJ, Hegazy A, Elmetwally RA, Wahby I. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Egypt: a multicenter case-control study. Int J Occup Environ Med . 2012;3:107–116. [PubMed] [Google Scholar]
  • 28. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ . 1990;301:1015–1017. doi: 10.1136/bmj.301.6759.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet . 1996;347:284–289. doi: 10.1016/s0140-6736(96)90465-1. [DOI] [PubMed] [Google Scholar]
  • 30. Mullen J, Hodgson MJ, DeGraff CA, Godar T. Case-control study of idiopathic pulmonary fibrosis and environmental exposures. J Occup Environ Med . 1998;40:363–367. doi: 10.1097/00043764-199804000-00011. [DOI] [PubMed] [Google Scholar]
  • 31. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, et al. Collaborating Centers Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol . 2000;152:307–315. doi: 10.1093/aje/152.4.307. [DOI] [PubMed] [Google Scholar]
  • 32. Gustafson T, Dahlman-Höglund A, Nilsson K, Ström K, Tornling G, Torén K. Occupational exposure and severe pulmonary fibrosis. Respir Med . 2007;101:2207–2212. doi: 10.1016/j.rmed.2007.02.027. [DOI] [PubMed] [Google Scholar]
  • 33. García-Sancho C, Buendía-Roldán I, Fernández-Plata MR, Navarro C, Pérez-Padilla R, Vargas MH, et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med . 2011;105:1902–1907. doi: 10.1016/j.rmed.2011.08.022. [DOI] [PubMed] [Google Scholar]
  • 34. Abramson MJ, Murambadoro T, Alif SM, Benke GP, Dharmage SC, Glaspole I, et al. Australian IPF Registry Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study. Thorax . 2020;75:864–869. doi: 10.1136/thoraxjnl-2019-214478. [DOI] [PubMed] [Google Scholar]
  • 35. Hubbard R, Cooper M, Antoniak M, Venn A, Khan S, Johnston I, et al. Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet . 2000;355:466–467. doi: 10.1016/S0140-6736(00)82017-6. [DOI] [PubMed] [Google Scholar]
  • 36. Miyake Y, Sasaki S, Yokoyama T, Chida K, Azuma A, Suda T, et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg . 2005;49:259–265. doi: 10.1093/annhyg/meh090. [DOI] [PubMed] [Google Scholar]
  • 37. Koo JW, Myong JP, Yoon HK, Rhee CK, Kim Y, Kim JS, et al. Occupational exposure and idiopathic pulmonary fibrosis: a multicentre case-control study in Korea. Int J Tuberc Lung Dis . 2017;21:107–112. doi: 10.5588/ijtld.16.0167. [DOI] [PubMed] [Google Scholar]
  • 38. Kim SY, Kang DM, Lee HK, Kim KH, Choi J. Occupational and environmental risk factors for chronic fibrosing idiopathic interstitial pneumonia in South Korea. J Occup Environ Med . 2017;59:e221–e226. doi: 10.1097/JOM.0000000000001153. [DOI] [PubMed] [Google Scholar]
  • 39. Johnston ID, Prescott RJ, Chalmers JC, Rudd RM, Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax . 1997;52:38–44. doi: 10.1136/thx.52.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sese L, Caliez J, Annesi-Maesano I, et al. Low income and outcome in idiopathic pulmonary fibrosis: an association to uncover Respir. Med 2021183106415. [DOI] [PubMed] [Google Scholar]
  • 41. Lee SH, Kim DS, Kim YW, Chung MP, Uh ST, Park CS, et al. Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis: a Korean national survey. Chest . 2015;147:465–474. doi: 10.1378/chest.14-0994. [DOI] [PubMed] [Google Scholar]
  • 42. Lee CT, Adegunsoye A, Chung JH, Ventura IB, Jablonski R, Montner S, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest . 2021;160:209–218. doi: 10.1016/j.chest.2021.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Liviero F, Mason P, Guarnieri G, Scarpa M, Balestro E, Maestrelli P. Progression of idiopathic pulmonary fibrosis in patients with past occupational exposure to dusts. Eur Respir J . 2017;50:PA407. [Google Scholar]
  • 44. Sengül B, Uzun O, Findik S, Atici AG, Erkan L. The evaluation of 92 interstitial lung disease patients. Tuberk Toraks . 2009;57:314–326. [PubMed] [Google Scholar]
  • 45. Toyoshima M, Fukada A, Yasui H, et al. Clinical features of idiopathic pulmonary fibrosis differ by sex. Am J Respir Crit Care Med . 2020;201 [Google Scholar]
  • 46. Walters E, Glaspole I, Hopkins P, et al. Prevalence of occupational and environmental exposures in Australian patients with idiopathic pulmonary fibrosis (IPF) Respirology . 2015;20:86. [Google Scholar]
  • 47. Wuyts W, Bondue B, Dahlqvist C, Compere C, Slabbynck H, Bondue B, et al. PROOF: a prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: exposure in the interim report of 175 IPF patients. Eur Respir J . 2016;44(suppl 58):3785. [Google Scholar]
  • 48. Carlier S, Nasser M, Fort E, Lamouroux C, Si-Mohamed S, Chalabreysse L, et al. Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases. Respir Res . 2022;23:332. doi: 10.1186/s12931-022-02257-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Perluk TM, Friedman Regev I, Freund O, Kleinhendler E, Hershko T, Ben-Ami S, et al. Importance of physician history taking in complementing patient-reported interstitial lung disease questionnaire. BMC Pulm Med . 2022;22:489. doi: 10.1186/s12890-022-02294-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Alaa Rashad M, Ibrahim AK. Idiopathic pulmonary fibrosis (IPF) in upper Egypt, a single center study. Egypt J Chest Dis Tuberc . 2015;64:915–919. [Google Scholar]
  • 51. Politi BJ, Arena VC, Schwerha J, Sussman N. Occupational medical history taking: how are today’s physicians doing? A cross-sectional investigation of the frequency of occupational history taking by physicians in a major US teaching center. J Occup Environ Med . 2004;46:550–555. doi: 10.1097/01.jom.0000128153.79025.e4. [DOI] [PubMed] [Google Scholar]
  • 52. Blackley DJ, Halldin CN, Cohen RA, Cummings KJ, Storey E, Laney AS. Misclassification of occupational disease in lung transplant recipients. J Heart Lung Transplant . 2017;36:588–590. doi: 10.1016/j.healun.2017.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med . 2017;196:680–689. doi: 10.1164/rccm.201611-2201PP. [DOI] [PubMed] [Google Scholar]
  • 54. Morell F, Villar A, Montero MÁ, Muñoz X, Colby TV, Pipvath S, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med . 2013;1:685–694. doi: 10.1016/S2213-2600(13)70191-7. [DOI] [PubMed] [Google Scholar]
  • 55. Lee CT, Strek ME, Adegunsoye A, Wong AW, Assayag D, Cox G, et al. Inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology . 2022;27:635–644. doi: 10.1111/resp.14267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Kitamura H, Ichinose S, Hosoya T, Ando T, Ikushima S, Oritsu M, et al. Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis—elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases. Pathol Res Pract . 2007;203:575–585. doi: 10.1016/j.prp.2007.04.008. [DOI] [PubMed] [Google Scholar]
  • 57. Monso E, Tura JM, Marsal M, Morell F, Pujadas J, Morera J. Mineralogical microanalysis of idiopathic pulmonary fibrosis. Arch Environ Health . 1990;45:185–188. doi: 10.1080/00039896.1990.9936714. [DOI] [PubMed] [Google Scholar]
  • 58. Barchowsky A, O’Hara KA. Metal-induced cell signaling and gene activation in lung diseases. Free Radic Biol Med . 2003;34:1130–1135. doi: 10.1016/s0891-5849(03)00059-5. [DOI] [PubMed] [Google Scholar]
  • 59. Wu CH, Tang SC, Wang PH, Lee H, Ko JL. Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem . 2012;287:25292–25302. doi: 10.1074/jbc.M111.291195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Vanka KS, Shukla S, Gomez HM, James C, Palanisami T, Williams K, et al. Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. Eur Respir Rev . 2022;31:210250. doi: 10.1183/16000617.0250-2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Koga Y, Satoh T, Kaira K, Hachisu Y, Ishii Y, Yajima T, et al. Progression of idiopathic pulmonary fibrosis is associated with silica/silicate inhalation. Environ Sci Technol Lett . 2021;8:903–910. [Google Scholar]
  • 62. Kang W, Kim D, Kim MY, Kim B, Shin J, Kim EY, et al. Usual interstitial pneumonia associated with crystalline silica exposure in pneumoconiosis: a retrospective cohort study. J Occup Environ Med . 2021;63:e905–e910. doi: 10.1097/JOM.0000000000002399. [DOI] [PubMed] [Google Scholar]
  • 63. Nesti M, Marinaccio A, Gennaro V, Gorini G, Mirabelli D, Mensi C, et al. ReNaM Working Group Epidemiologic surveillance for primary prevention of malignant mesothelioma: the Italian experience. Med Lav . 2005;96:338–346. [PubMed] [Google Scholar]
  • 64. Jegal Y, Park JS, Kim SY, Yoo H, Jeong SH, Song JW, et al. Korea ILD Study Group Clinical features, diagnosis, management, and outcomes of idiopathic pulmonary fibrosis in Korea: analysis of the Korea IPF Cohort (KICO) Registry. Tuberc Respir Dis (Seoul) . 2022;85:185–194. doi: 10.4046/trd.2021.0123. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the American Thoracic Society are provided here courtesy of American Thoracic Society

RESOURCES